Status:
TERMINATED
Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents
Lead Sponsor:
Ana Radovic
Collaborating Sponsors:
NuRelm, Inc.
National Institute of Mental Health (NIMH)
Conditions:
Depression in Adolescence
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
The MoodRing intervention is a mobile application for adolescents, parents, and an accompanying web-based clinician portal which enables adolescents to monitor their mood through the use of passively ...
Detailed Description
This is a randomized controlled trial to evaluate the efficacy of MoodRing as compared to usual care for adolescents who have a prior diagnosis of depression. Adolescents with depressive symptoms, the...
Eligibility Criteria
Inclusion
- Adolescent:
- age 12 -18
- prior or present history of depression per self-report and/or clinician diagnosis
- scores between 5 or higher on PHQ-9 consistent with at least mild symptoms of depression
- read and understand English
- has an Android or iOS smartphone compatible with AWARE mobile application and access to a smartphone data plan
- currently in United States
- Parent/Guardian:
- adolescent qualifies for study and assents to enroll
- understands English
- currently in United States
- has a smartphone device that can download the intervention application
- Healthcare Provider:
- \- involved in providing mental health treatment (psychotherapy or antidepressant prescribing or making referrals) to adolescent participant - can be a primary care provider, therapist, subspecialist, psychiatrist
Exclusion
- Adolescent:
- currently actively suicidal (have suicidal thoughts and plan with an intent to act on it)
- plans to travel to countries belonging to the European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), the United Kingdom (England, Scotland, Wales, and Northern Ireland), Norway, Iceland, or Lichtenstein in the next 6 months for more than 2 weeks at a time
- Parent:
- \- If their adolescent child is excluded
- Healthcare Provider:
- \- None
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2024
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05376358
Start Date
May 12 2022
End Date
June 20 2024
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Adolescent and Young Adult Health
Pittsburgh, Pennsylvania, United States, 15213